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Abstract 
In this report, we update previously published results on all-
cause mortality in Switzerland in 2020 and extend them to the 
first half of 2021. Whereas mortality in Switzerland increased 
by 9.2% in 2020 compared with 2019 as a result of the first two 
waves of COVID-19, it decreased by about 10.8 % in the first 
half of 2021 compared with 2020, bringing the level of mortality 
in 2021 below that of 2019. In terms of life expectancy, we have 
gained about 3.1 months so far in 2021 in Switzerland 
compared to 2019, 6.0 months for women and 0.3 months for 
men. By mid-2021, women have therefore more than 
recovered the secular downward trend in mortality, i.e. an 
increase in life expectancy of about 2 months each year, while 
men are still slightly behind. A look at the weekly mortality 
data reveals that mortality levels in 2021 were consistently 
lower than those observed in previous years, with the 
exception of the first 4-6 weeks of 2021, corresponding to the 
end of the second wave of COVID-19. Notably, 2021 is the 
second consecutive year without a visible impact of influenza 
on mortality in Switzerland, and there was no third wave of 
mortality related to COVID-19. Therefore, 2021 is so far the 
best year ever regarding mortality in Switzerland. 
Résumé  
Dans ce rapport, nous mettons à jour les résultats précédemment 
publiés sur la mortalité toutes causes confondues en Suisse en 2020 
et les étendons au premier semestre 2021. Alors que la mortalité en 
Suisse a augmenté de 9,2 % en 2020 par rapport à 2019 suite aux 
deux premières vagues de COVID-19, elle a diminué d'environ 10,8 
% au premier semestre 2021 par rapport à 2020, ramenant le niveau 
de mortalité en 2021 en dessous de celui de 2019. En termes 
d'espérance de vie, nous avons gagné en Suisse environ 3,1 mois 
jusqu'à présent en 2021 par rapport à 2019, 6,0 mois pour les 
femmes et 0,3 mois pour les hommes. À la mi-2021, les femmes ont 
donc plus que récupéré la tendance séculaire à la baisse de la 
mortalité, soit une augmentation de l'espérance de vie d'environ 2 
mois chaque année, alors que les hommes sont encore légèrement 
en retard. Une analyse des données hebdomadaires de mortalité 
révèle que les niveaux de mortalité en 2021 étaient 
systématiquement inférieurs à ceux observés les années 
précédentes, à l'exception des 4 à 6 premières semaines de 2021, 
correspondant à la fin de la deuxième vague de COVID-19. En 
particulier, 2021 est la deuxième année consécutive sans impact 
visible de la grippe sur la mortalité en Suisse, et nous n’avons pas 
observé de troisième vague de mortalité liée au COVID-19. Par 
conséquent, 2021 est jusqu'à présent la meilleure année jamais 
enregistrée en matière de mortalité en Suisse. 
Introduction 
The year 2020 was marked by the global spread of the 
COVID-19 pandemic caused by severe acute respiratory 
syndrome coronavirus 2 (SARS-CoV-2). The impact of the 
pandemic on all-cause mortality has begun to be studied 
worldwide [1-5], with the difficulty that it usually takes 
several months (or years) to obtain complete and 
consolidated statistics on deaths in a country. 
An early assessment of excess mortality in Switzerland in 
2020 can be found in Locatelli and Rousson [6] (fully 
published on June 17, 2021). Based on provisional data 
collected until May 19, 2021 from the Swiss FSO (Federal 
Statistical Office), they estimated in 2020 an increase in 
standardized mortality rates of 8.8% compared with 2019, 
with significant excess mortality (only) for men over 70 and 
for women over 75. The estimated decrease in life 
expectancy at birth in 2020 was 0.7%, with a loss of 9.7 
months for men and 5.3 months for women with respect to 
the previous year.  
A few months later, these results can be updated using the 
completed death data now available for 2020, and 
extended using the (provisional) death data for the first half 
of 2021. The purpose of this report is therefore two-fold. 
First, to update the results published in [6]. Second, to 
provide an early analysis of the mortality in Switzerland in 
the first half of 2021. While recognizing that semiannual 
analyses are not common in demography, and that death 
statistics for the first half of the current year are still 
provisional (because some deaths are reported with delay), 
we believe that such an early analysis is interesting and 
useful to judge and follow the situation during the ongoing 
pandemic. 
Data 
We used official data on deaths in Switzerland published by 
the Swiss FSO for 2000-2020 and the first six months (26 
weeks) of 2021 (last access September 28, 2021). The 
annual number of deaths, separately for men and women, 
was available by 1-year age groups (with a last open class of  
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Figure 1. Standardized Weekly Deaths 2015-2021 (data: FSO) 
110+) until year 2020a. On the other hand, it was available 
by 5-years age groups (with a last open class of 90+) for 
each of the first 26 weeks of 2021b. To facilitate 
comparisons, we excluded 1/366 of deaths in the case of 
leap years (including 2020). Weekly death data were also 
available for years 2015-2020 with a partition in 5 large age 
classes (0-19, 20-39, 40-64, 65-79, 80+)c. 
The size of the Swiss population as of January 1, 2011-2021, 
stratified by sex and one-year age groups (with a last open 
class of 105+) was found in the FSO databased. The size of 
the Swiss population as of January 1, 2000-2019, stratified 
by sex and one-year age groups (with a last open class of 
110+), was (also) found in the Human Mortality Database 
(HMD)e. Since the difference for the overlapping years were 
negligible, we used HMD source for the years 2000-2010 
and FSO source for the years 2011-2021. Life expectancy 
for both sexes was also available in the HMD database for 
the period 1900-2018.     
Results 
Figure 1 shows the Standardized Weekly Deaths (SWD, see 
Methodological Appendix) for the years 2015-2020 and for 
the first 26 weeks of the year 2021, reflecting the weekly 
deaths that would have occurred each year if the weekly 
age-specific rates observed in that year were applied to the 
size and age distribution of a reference population 
(reference = January 1, 2021). We recognize the waves due 
to influenza each year until 2019 (except 2016, a year 
spared by the flu) and the two COVID-19 waves of 2020, the 
first one “replacing” the usual wave of influenza, the second 
one (much higher and broader than the first) ending during 
the first 4-6 weeks of 2021. With the exception of these 
initial weeks, the first half of 2021 was characterized by 
lower levels of mortality than in the corresponding period 
of the 6 previous years. In particular, neither an episode of 
flu nor a third wave of COVID-19 was observed. 
Figure 2 shows the Standardized Mortality Rates (SMR, see 
Methodological Appendix) in Switzerland calculated for the 
years 2000-2020 and for the first half of 2021 (overall and 
stratified by sex). Crude mortality rates (number of deaths 
divided by the total population in a given year) are plotted 
for comparison. We also added to each graph an estimated 
trend based on the SMR of the pre-pandemic decade 2010-
2019, as explained in the Methodological Appendix. As 
already discussed in [6], and contrary to the crude mortality 
rates, the standardized mortality rates declined sharply 
over the past 20 years. In 2020, the SMR for both sexes was 
higher than in previous years, returning to the level of 
about 5 years earlier. However, and this is a new result, the 
SMR in the first half of 2021 was lower than in 2020 and all 
previous years (including 2019), falling just below the 
projected trend for mid-2021. Similar conclusions can be 
drawn by analyzing men and women separately, although 
the SMR for men was still above the trend in the first half of 
2021, whereas it was below the trend for women.  
Table 1 shows the relative changes in SMR, comparing 
2021, 2020 and 2019. Mortality in 2020 increased by 9.2% 
compared with 2019, this relative difference being greater 
for men (11.0%) than for women (7.4%). On the other hand, 
the SMR for the first half of 2021 decreased by 10.8% 
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(10.3% for men and 11.3% for women) compared with the 
SMR for 2020, being thus 2.7% lower than in 2019, and just 
below the projected trend for mid-2021 (-0.2%). 
Consistently with Figure 2, the relative difference from the 








Figure 2: Mortality rates 2000-21 overall and by sex (data: FSO) 
  SMR  
 Total Men Women 
 % % % 
2020 vs 2019 +9.2  +11.0 +7.4 
mid-2021 vs 2019 -2.7 -0.5 -4.7 
mid-2021  vs 2020 -10.8 -10.3 -11.3 
mid-2021  vs trend -0.2 +2.9 -3.0 
Table 1: Relative changes in Standardized Mortality Rates (SMR)  
Figure 3 shows life expectancy at birth in Switzerland for 
the years 1900-2020 and the first half of 2021, separately 
for men and women (see Methodological Appendix). We 
retrieve the spectacular increase in life expectancy during 
period 1900-2019 (from 46 to 81.9 years for men and from 
49 to 85.6 years for women) with the impressive drop due 
to the Spanish flu in 1918, a loss of life expectancy of more 
than 8 years for women and more than 10 years for men. 
Considering the decade 2010-2019, we estimated an 
increasing linear trend of around 2.5 months per year for 
men and 1.6 months per year for women.  
Table 2 shows the relative changes in life expectancy, 
comparing 2021, 2020 and 2019. Compared to 2019, life 
expectancy decreased in 2020 by 1% (10.1 months) for men 
and 0.6% (5.8 months) for women. However, as for 
standardized mortality rates, life expectancy resumed its 
upward trend in the first half of 2021, remaining stilly below 
the trend for men (-0.3%, -3.0 months) but appearing  
above the trend for women (+0.3%, +3.6 months). 
Discussion 
In this report, we updated the results obtained in Locatelli 
and Rousson [6], "A first analysis of excess mortality in 
Switzerland in 2020", using the consolidated FSO death 
data. We estimate now the excess mortality in 2020 
compared to 2019 at +9.2% (instead of +8.8%), +11.0% for 
men and +7.4% for women, and the loss in life expectancy 
between 2019 and 2020 at -7.9 months (instead of -7.5 
months), -10.1 months for men and -5.8 months for 
women. All these results remain close to what has been 
published in [6]. 
As we now dispose of provisional data on deaths for the 
first six months (first 26 weeks) of 2021, we could also 
estimate the semiannual standardized mortality rate and 
the corresponding life expectancy at birth for the first half 
of 2021. These data could be compared with the 
standardized mortality rates and life expectancies of 2020, 
2019, and with the projected trends for mid-2021. 
According to our estimates, the SMR of mid-2021 has 
decreased by 10.8% and life expectancy at birth have 
increased by 1.1% (11.2 months) compared to 2020. As a 
result, both seem to have already recovered the pre-
pandemic trend lost in 2020. When stratifying by sex, we 
found that women have actually more than retrieved the 
previous tendency, while men are still slightly below. These 
results are at least partly due to the fact that, apart from 
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the first 4-6 weeks of the year, characterized by the ending 
of the second wave of COVID-19, the first half of 2021 has 
been free of influenza. However, the standardized weekly 
deaths for the first semester 2021 appear uniformly lower 
than those of previous years, also after the winter, outside 
the usual periods of influenza. Furthermore, contrary to the 
first and second waves, the third wave of COVID-19 cases 
registered in Switzerland during the months of March and 
April 2021 had no visible impact on all-cause mortality.  
This analysis is still a preliminary one and requires some 
caution and clarifications. First, the deaths reported up to 
week 26 of 2021 are provisional, as part of the deaths are 
recorded with delay. However, three months after the last 
week considered (the 26th), the number of deaths recorded 
up to this week is not far from having stabilized, as we could 
verify by repeating the analysis for the last weeks. Second, 
when we compare the standardized mortality rate and the 
life expectancy of the first semester 2021 with that of 
previous years and with the projected trend, we implicitly 
rely on the fact that a “typical” first semester contains 
around half of the year's deaths. This assumption is 
however in line with what has been observed during the last 
few years, where consistently slightly more deaths 
occurred in the first than in the second semester, which 
makes our comparison with the trend slightly conservative. 
The single exception was of course 2020, where more 
deaths occurred during the second part of the year due to 
the second wave of COVID-19.  Therefore, in an ongoing 
pandemic situation, our estimates of the standardized 
mortality rate and life expectancy at mid-2021 are not 
intended to be a prediction of what will be observed at the 
end of the year. This analysis is just a useful indication that 
2021 has so far been a good year (in fact the best year ever) 
for mortality in Switzerland, perfectly in line with the 
continuous progress of humanity in this regard. 
 
Figure 3: Life expectancy at birth 1900-2021 (data: SFO/HMD)
  
Life Expectancy 
 Total Men Women 
 % Months % Months % Months 
2020 vs 2019 -0.8 -7.9 -1.0 -10.1 -0.6  -5.8  
mid-2021 vs 2019 +0.3 +3.1 +0.0 +0.3 +0.6 +6.0 
mid-2021  vs 2020 +1.1 +11.2 +1.1 +10.4 +1.2 +11.8 
mid-2021  vs trend +0.0 +0.3 -0.3 -3.0 +0.3 +3.6 
Table 2: Relative changes in life expectancy at birth
Methodological Appendix 
In order to compare the number of weekly deaths across years 
while accounting for the increase and aging of the population, 
weekly deaths series for years 2015-2020 and first half of 2021 
were standardized using the 5 available age classes (0-19, 20-39, 
40-64, 65-79, 80+). Standardized Weekly Deaths (SWD) ?̇?𝑠
𝑦,𝑤
 (𝑦 = 












In this formula 𝐷𝑘
𝑦,𝑤
 represents the number of observed deaths for 
year 𝑦 (𝑦 = 2015-2020), week 𝑤 (𝑤 = 1,…,52) and age class 𝑘 (𝑘 =
1, … ,5), 𝑃𝑘
𝑦
 is the population of age class 𝑘 as of January 1 of year 
𝑦, and 𝑠 is the reference year. Of note, by choosing the year 2021 
as the reference year (𝑠=2021), the standardized weekly deaths 
for (the first 26 weeks of) 2021 coincide with the observed weekly 
deaths 𝐷2021,𝑤= ∑ 𝐷𝑘
2021,𝑤5
𝑘=1  that year, that is ?̇?𝑠
2021,𝑤 =
𝐷2021,𝑤 (𝑤 = 1,…,26). 
To compare mortality in the first half of 2021 with that of previous 
years we used (one-year of) age and sex Standardized Mortality 
Rates (SMR), considering population as of January 1, 2021 as the 
standard. The SMRs for years 𝑦 (𝑦=2000,…,2020), 𝑚𝑠
𝑦
, are 




















 are annual deaths and population size 
(as of January 1) in year 𝑦 (𝑦 = 2000,…,2020) for age 𝑖 (𝑖 = 
0,1,…99,100+) and sex 𝑗 (𝑗=1 for men and 𝑗=2 for women), while 
𝑃𝑖𝑗
𝑠  is the population of age 𝑖 and sex 𝑗 as of January 1 of the 
reference year 𝑠 (𝑠=2021), and 𝑃𝑠 the total population as of 




𝑖=0 .  
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The SMR for the first half of the reference year 𝑠=2021 






In this formula 𝐷𝑚𝑖𝑑−2021  represents the number of deaths 
observed during the first 26 weeks of 2021. As usual for a crude 
mortality rate, the denominator is expressed in person-years. 
Since only six months are considered here, the size of the 
population in the denominator had thus to be multiplied by 0.5. 
Note that we are updating the results of [6] with a slightly 
different standardization, using 2021 instead of 2020 as the 
reference year, in order to be able to include the year 2021 for 
which we have broader age classes. This had however almost no 
impact on the results, as such comparisons do not depend much 
of the reference year chosen [7]. 
In order to update results of [6], we compared 𝑚𝑠
2020  with 𝑚𝑠
2019 




2019. We did the same comparison for 





 and 𝑦 = 
2019, 2020. In addition, to account for the expected reduction of 
mortality along the years, which reflects the undeniable and 
remarkable human progress in this regard, we estimated a linear 
trend on the standardized mortality rates 𝑚𝑠
𝑦
 based on 10 years 
before pandemic 𝑦 = 2010-2019 using linear regression: 
𝑚𝑠
𝑦
= 𝛼 + 𝛽𝑦            𝑦 = 2010, … ,2019 
We then compared the observed SMR for the first half of 2021 
with the one predicted according to this trend for the middle of 
2021, ?̂?𝑠




𝑚𝑖𝑑−2021 (?̂? and ?̂? are estimated 
regression parameters). Predicting the SMR for the middle of a 
year, in our case 2021, from data on previous annual SMRs can be 
justified by the fact that the number of deaths in the first half of a 
year roughly corresponds (on average) to the number of deaths in 
the second half of the year. For example, considering the years 
2015 to 2019, the percentage of annual deaths observed in the 
first half of the year ranged from 50.2% in 2016 to 52.9% in 2015  
(while it was 47.6% in 2020 due to the second wave of COVID-19). 
This means that our predicted SMR for the first half of 2021 might 
be indeed slightly too optimistic, our analysis being conservative 
on this point. 
In order to give more weight to the deaths of young people 
compared to the deaths of older people (while not needing to 
define a reference year), an alternative way to express mortality 
in a given year 𝑦 and for a given sex 𝑗 is to calculate the Life 
expectancy at birth 𝑒0𝑗
𝑦
 obtained from the age and sex specific 
mortality rates observed in that year. Using the same method [8] 
detailed in [6], and based on age stratification into 5-years age 
classes (last open class 90+), the one for which deaths were 
available for 2021, we updated the calculation of life expectancy 
for 2020, 𝑒0𝑗
2020 (𝑗 = 1 for men and 2 for women) published in [6]. 
We could similarly calculate men and women life expectancy for 
the first half of 2021, 𝑒0𝑗
𝑚𝑖𝑑−2021. Other estimations of life 
expectancies are taken from [6] for 1970 - 2019 and from the HMD 
database for 1900 - 1969.  As in [6] and with the same aim of 
updating their results, we compared 𝑒0𝑗
2020  with 𝑒0𝑗
2019 either via a 




via an absolute change (expressed in months), 12(𝑒0𝑗
2020 − 𝑒0𝑗
2019). 
A similar comparison was performed for the first half of 2021 via 
100(𝑒0𝑗





𝑚𝑖𝑑− 2021 − 𝑒0𝑗
𝑦
) with 𝑦 = 
2019, 2020. As for the SMRs, and using a similar justification, we 
also estimated a linear trend by fitting the men and women life 
expectancies at birth 𝑒0𝑗
𝑦




= 𝛼𝑗 + 𝛽𝑗𝑦          𝑦 = 2010, … ,2019    ;    𝑗 = 1,2 
We then compared (via a relative and absolute difference) the 
estimated life expectancies of the first half 2021, 𝑒0𝑗
𝑚𝑖𝑑−2021 (𝑗 =
1,2) , with the ones predicted according to the trend for the 
middle of 2021: ?̂?0𝑗
𝑚𝑖𝑑− 2021 = ?̂?𝑗 + ?̂?𝑗 ∙ 2020.5,   𝑗 = 1,2. 
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